Telomerase regulation at the crossroads of cell fate

被引:58
作者
Cukusic, A. [1 ]
Vidacek, N. Skrobot [1 ]
Sopta, M. [2 ]
Rubelj, I. [1 ]
机构
[1] Rudjer Boskovic Inst, Expt Cancerol Lab, Dept Mol Biol, Zagreb 10000, Croatia
[2] Rudjer Boskovic Inst, Lab Gene Regulat, Dept Mol Biol, Zagreb 10000, Croatia
关键词
D O I
10.1159/000167812
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomeres are specialized structures at the ends of eukaryotic chromosomes and are crucial for genome stability, cell growth control and carcinogenesis. Normally, they protect chromosomes from end to end fusion, degradation and recombination. Telomerase is a ribonucleoprotein essential for maintenance of telomeres and it is active in germ cells, stem cells and similar to 90% of cancers but not in most normal somatic cells. Human telomerase catalytic protein subunit hTERT is crucial for telomerase activity. Although hTERT expression is sufficient to immortalize normal human cells in culture, spontaneous immortalization is extremely rare which suggests that its expression is under strong negative control. Characterization of the hTERT promoter has allowed for the analysis of potential mechanisms of hTERT expression and regulation. The hTERT promoter is very complex and contains a great number of canonical and non-canonical sequences that bind or potentially bind a variety of transcription factors. In this review we focus on the positive and negative regulators of hTERT transcription and their role in normal cell growth and immortalization. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:263 / 272
页数:10
相关论文
共 115 条
[1]  
Aldous WK, 1999, CANCER, V85, P1523, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1523::AID-CNCR13>3.3.CO
[2]  
2-G
[3]   p53-induced apoptosis as a safeguard against cancer [J].
Asker, C ;
Wiman, KG ;
Selivanova, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :1-6
[4]   A SWITCH FROM MYC-MAX TO MAD-MAX HETEROCOMPLEXES ACCOMPANIES MONOCYTE/MACROPHAGE DIFFERENTIATION [J].
AYER, DE ;
EISENMAN, RN .
GENES & DEVELOPMENT, 1993, 7 (11) :2110-2119
[5]   Regulation of telomerase activity by the p53 family member p73 [J].
Beitzinger, M ;
Oswald, C ;
Beinoraviciute-Kellner, R ;
Stiewe, T .
ONCOGENE, 2006, 25 (06) :813-826
[6]   Vitamin E suppresses telomerase activity in ovarian cancer cells [J].
Bermudez, Yira ;
Ahmadi, Shirrin ;
Lowell, Nancy E. ;
Kruk, Patricia A. .
CANCER DETECTION AND PREVENTION, 2007, 31 (02) :119-128
[7]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[8]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[9]   Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization [J].
Bryce, LA ;
Morrison, N ;
Hoare, SF ;
Muir, S ;
Keith, WN .
NEOPLASIA, 2000, 2 (03) :197-201
[10]   Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma [J].
Chen, Cheng-Jueng ;
Kyo, Satoru ;
Liu, Yao-Chi ;
Cheng, Yeung-Leung ;
Hsieh, Chung-Bao ;
Chan, De-Chuan ;
Yu, Jyh-Cherng ;
Harn, Horng-Jyh .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (05) :638-642